Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 papers

DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM


  Autoimmune Disorders

  Free Subscription


Articles published in Acta Neurol Scand

Retrieve available abstracts of 90 articles:
HTML format



Single Articles


    May 2020
  1. ZANONI M, Orlandi E, Rossetti G, Turatti M, et al
    Up-regulated serum miR-128-3p in progressive and relapse-free multiple sclerosis patients.
    Acta Neurol Scand. 2020 May 20. doi: 10.1111/ane.13288.
    PubMed     Abstract available


  2. ZHU F, Shan W, Lv R, Li Z, et al
    Clinical characteristics of GAD 65 associated autoimmune encephalitis.
    Acta Neurol Scand. 2020 May 16. doi: 10.1111/ane.13281.
    PubMed     Abstract available


  3. COSTA ARPIN E, Naveiro Soneira J, Lema Bouzas M, Quintela AG, et al
    Epidemiology of multiple sclerosis IN Santiago de Compostela (Spain).
    Acta Neurol Scand. 2020 May 11. doi: 10.1111/ane.13265.
    PubMed     Abstract available


    April 2020
  4. CHOU CC, Huang MH, Lan WC, Kong SS, et al
    Prevalence and risk of thyroid diseases in myasthenia gravis.
    Acta Neurol Scand. 2020 Apr 23. doi: 10.1111/ane.13254.
    PubMed     Abstract available


    March 2020
  5. REYES S, Suarez S, Allen-Philbey K, Thomson A, et al
    The impact of social capital on patients with multiple sclerosis.
    Acta Neurol Scand. 2020 Mar 18. doi: 10.1111/ane.13244.
    PubMed     Abstract available


  6. LAAKSO SM, Hekali O, Kurdo G, Martola J, et al
    Trigeminal neuralgia in multiple sclerosis: prevalence and association with demyelination.
    Acta Neurol Scand. 2020 Mar 18. doi: 10.1111/ane.13243.
    PubMed     Abstract available


  7. LOTAN I, Benninger F, Hellmann MA, Sicsic C, et al
    Incidence of AChR -Ab positive myasthenia gravis in Israel: A population- based study.
    Acta Neurol Scand. 2020 Mar 7. doi: 10.1111/ane.13239.
    PubMed     Abstract available


  8. WILSKI M, Kocur P, Brola W, Tasiemski T, et al
    Psychological factors associated with self-management in multiple sclerosis.
    Acta Neurol Scand. 2020 Mar 2. doi: 10.1111/ane.13236.
    PubMed     Abstract available


  9. ZARGHAMI A, Nourmohammadi ST, Hojjati SMM
    Urbanization theory and socioeconomic changeover of multiple sclerosis in Iran.
    Acta Neurol Scand. 2020;141:256.
    PubMed    


    February 2020
  10. RASMAN A
    Air pollution, a risk factor for multiple sclerosis?
    Acta Neurol Scand. 2020 Feb 25. doi: 10.1111/ane.13235.
    PubMed     Abstract available


    January 2020
  11. HELLGREN J, Risedal A, Kallen K
    Rituximab in multiple sclerosis at general hospital level.
    Acta Neurol Scand. 2020 Jan 28. doi: 10.1111/ane.13225.
    PubMed     Abstract available


  12. TURK BORU U, Boluk C, Tasdemir M, Gezer T, et al
    Air pollution, a possible risk factor for multiple sclerosis.
    Acta Neurol Scand. 2020 Jan 18. doi: 10.1111/ane.13223.
    PubMed     Abstract available


    December 2019
  13. MURTONEN A, Sumelahti ML
    Multiple sclerosis prevalence in 2000 and 2010 in Western Finland.
    Acta Neurol Scand. 2019 Dec 14. doi: 10.1111/ane.13203.
    PubMed     Abstract available


  14. LIU X, Zhang L, Chen C, Gong X, et al
    Long-term cognitive and neuropsychiatric outcomes in patients with anti-NMDAR encephalitis.
    Acta Neurol Scand. 2019;140:414-421.
    PubMed     Abstract available


    November 2019
  15. DJORDJEVIC G, Stojanov A, Bozovic I, Berisavac I, et al
    Six-month prospective study of quality of life in Guillain-Barre syndrome.
    Acta Neurol Scand. 2019 Nov 8. doi: 10.1111/ane.13195.
    PubMed     Abstract available


  16. WALLIS O, Bol Y, Kohler S, van Heugten C, et al
    Anxiety in multiple sclerosis is related to depressive symptoms and cognitive complaints.
    Acta Neurol Scand. 2019 Nov 6. doi: 10.1111/ane.13191.
    PubMed     Abstract available


  17. SCOTT TF, Diehl D, Elmalik W, Gettings EJ, et al
    Multiple sclerosis relapses contribute to long-term disability.
    Acta Neurol Scand. 2019;140:336-341.
    PubMed     Abstract available


    October 2019
  18. SMOLDERS J, Mimpen M, Oechtering J, Damoiseaux J, et al
    Vitamin D3 supplementation and neurofilament light chain in multiple sclerosis.
    Acta Neurol Scand. 2019 Oct 28. doi: 10.1111/ane.13185.
    PubMed     Abstract available


  19. ZETTERBERG H
    Plasma neurofilament light in progressive multiple sclerosis.
    Acta Neurol Scand. 2019 Oct 16. doi: 10.1111/ane.13184.
    PubMed     Abstract available


  20. CASTREN E, Heinonen T, Makinen K, Hamalainen P, et al
    The rate of neuropsychological assessments in multiple sclerosis has increased - A retrospective study in a Finnish central hospital.
    Acta Neurol Scand. 2019 Oct 4. doi: 10.1111/ane.13175.
    PubMed     Abstract available


    July 2019
  21. FERRARO D, Guicciardi C, De Biasi S, Pinti M, et al
    Plasma Neurofilaments correlate with Disability in Progressive Multiple Sclerosis patients.
    Acta Neurol Scand. 2019 Jul 27. doi: 10.1111/ane.13152.
    PubMed     Abstract available


  22. TOLF A, Fagius J, Carlson K, Akerfeldt T, et al
    Sustained remission in multiple sclerosis after hematopoietic stem cell transplantation.
    Acta Neurol Scand. 2019 Jul 12. doi: 10.1111/ane.13147.
    PubMed     Abstract available


  23. PAKDEL M, Hedstrom A, Bidkhori M, Hadei M, et al
    Do socio-economic factors affect prevalence of multiple sclerosis in Iran?
    Acta Neurol Scand. 2019 Jul 10. doi: 10.1111/ane.13148.
    PubMed     Abstract available


  24. LAAKSO SM, Viitala M, Kuusisto H, Sarasoja T, et al
    Multiple sclerosis in Finland 2018- data from the national register.
    Acta Neurol Scand. 2019 Jul 4. doi: 10.1111/ane.13145.
    PubMed     Abstract available


  25. GUGER M, Enzinger C, Leutmezer F, Kraus J, et al
    Real-life use of oral disease-modifying treatments in Austria.
    Acta Neurol Scand. 2019;140:32-39.
    PubMed     Abstract available


    May 2019
  26. GASCOYNE CR, Simpson S Jr, Chen J, van der Mei I, et al
    Modifiable factors associated with depression and anxiety in multiple sclerosis.
    Acta Neurol Scand. 2019 May 23. doi: 10.1111/ane.13132.
    PubMed     Abstract available


  27. DE FLON P, Laurell K, Sundstrom P, Blennow K, et al
    Comparison of plasma and cerebrospinal fluid neurofilament light in a multiple sclerosis trial.
    Acta Neurol Scand. 2019;139:462-468.
    PubMed     Abstract available


  28. AXELSSON M, Dubuisson N, Novakova L, Malmestrom C, et al
    Cerebrospinal fluid NCAM levels are modulated by disease-modifying therapies.
    Acta Neurol Scand. 2019;139:422-427.
    PubMed     Abstract available


    March 2019
  29. SEDANO MJ, Orizaola P, Gallardo E, Garcia A, et al
    A unicenter, prospective study of Guillain-Barre syndrome in Spain.
    Acta Neurol Scand. 2019 Mar 31. doi: 10.1111/ane.13092.
    PubMed     Abstract available


  30. CORTES-MARTINEZ A, Matias-Guiu JA, Pytel V, Montero P, et al
    What is the meaning of PASAT rejection in Multiple Sclerosis?
    Acta Neurol Scand. 2019 Mar 25. doi: 10.1111/ane.13090.
    PubMed     Abstract available


    February 2019
  31. ENGELS K, Schiffmann I, Weierstall R, Rahn AC, et al
    Emotions towards magnetic resonance imaging in people with multiple sclerosis.
    Acta Neurol Scand. 2019 Feb 25. doi: 10.1111/ane.13082.
    PubMed     Abstract available


  32. DE BERNARDO M, Vitiello L, Rosa N
    Optic nerve ultrasound measurement in multiple sclerosis.
    Acta Neurol Scand. 2019 Feb 5. doi: 10.1111/ane.13072.
    PubMed     Abstract available


  33. CANDELIERE MERLICCO A, Gabaldon Torres L, Villaverde Gonzalez R, Fernandez Romero I, et al
    Response to: Comment on "Transorbital ultrasonography for measuring optic nerve atrophy in multiple sclerosis".
    Acta Neurol Scand. 2019 Feb 5. doi: 10.1111/ane.13076.
    PubMed     Abstract available


  34. SANDROFF BM, Baird JF, Silveira SL, Motl RW, et al
    Response heterogeneity in fitness, mobility and cognition with exercise-training in MS.
    Acta Neurol Scand. 2019;139:183-191.
    PubMed     Abstract available


  35. DASH D, Pandey S
    Movement disorders associated with neuronal antibodies.
    Acta Neurol Scand. 2019;139:106-117.
    PubMed     Abstract available


    January 2019
  36. NAGAPPA M, Mahadevan A, Yashwanth G, Patil SA, et al
    Autoantibodies in Acquired Myasthenia gravis: Clinical Phenotype & Immunological correlation.
    Acta Neurol Scand. 2019 Jan 28. doi: 10.1111/ane.13071.
    PubMed     Abstract available


  37. RAHN AC, Kopke S, Stellmann JP, Schiffmann I, et al
    Magnetic resonance imaging as a prognostic disability marker in clinically isolated syndrome: A systematic review.
    Acta Neurol Scand. 2019;139:18-32.
    PubMed     Abstract available


    November 2018
  38. PIRTTISALO AL, Soilu-Hanninen M, Sipila JOT
    Multiple sclerosis epidemiology in Finland: regional differences and high incidence.
    Acta Neurol Scand. 2018 Nov 27. doi: 10.1111/ane.13057.
    PubMed     Abstract available


  39. DAL-BIANCO A, Wenhoda F, Rommer PS, Weber M, et al
    Do Elevated Autoantibodies in Patients With Multiple Sclerosis Matter ?
    Acta Neurol Scand. 2018 Nov 17. doi: 10.1111/ane.13054.
    PubMed     Abstract available


  40. MELBYE P, Olsson A, Hansen TH, Sondergaard HB, et al
    Short-Chain Fatty Acids and Gut Microbiota in Multiple Sclerosis.
    Acta Neurol Scand. 2018 Nov 14. doi: 10.1111/ane.13045.
    PubMed     Abstract available


  41. STEENHOF M, Nielsen NM, Stenager E, Kyvik K, et al
    Distribution of disease courses in familial versus sporadic multiple sclerosis.
    Acta Neurol Scand. 2018 Nov 9. doi: 10.1111/ane.13044.
    PubMed     Abstract available


  42. DOURADO JUNIOR MET, Fernandes UT, Ramos ES, Vital ALF, et al
    Egos has a reduced capacity to predicts GBS prognosis in Northeast Brazil.
    Acta Neurol Scand. 2018;138:459-462.
    PubMed     Abstract available


    October 2018
  43. HOLMOY T, Rosjo E, Zetterberg H, Blennow K, et al
    Vitamin D supplementation and neurofilament light chain in multiple sclerosis.
    Acta Neurol Scand. 2018 Oct 13. doi: 10.1111/ane.13037.
    PubMed     Abstract available


  44. BAYART JL, Muls N, van Pesch V
    Free Kappa light chains in neuroinflammatory disorders: Complement rather than substitute?
    Acta Neurol Scand. 2018;138:352-358.
    PubMed     Abstract available


    August 2018
  45. WESTERBERG E, Landtblom AM, Punga AR
    Life-style factors and disease-specific differences in subgroups of Swedish Myasthenia Gravis.
    Acta Neurol Scand. 2018 Aug 28. doi: 10.1111/ane.13017.
    PubMed     Abstract available


  46. HAGHIGHI S, Forsmark S, Carlsson A, Nilsson MKL, et al
    Open study with (-)-OSU6162 in multiple sclerosis-related fatigue.
    Acta Neurol Scand. 2018 Aug 22. doi: 10.1111/ane.13007.
    PubMed     Abstract available


  47. BAUMGARTNER A, Frings L, Schiller F, Stich O, et al
    Regional neuronal activity in patients with relapsing remitting multiple sclerosis.
    Acta Neurol Scand. 2018 Aug 8. doi: 10.1111/ane.13012.
    PubMed     Abstract available


    July 2018
  48. MURLEY C, Yang F, Gyllensten H, Alexanderson K, et al
    Disposable income trajectories of working-aged individuals with diagnosed multiple sclerosis.
    Acta Neurol Scand. 2018 Jul 24. doi: 10.1111/ane.13001.
    PubMed     Abstract available


  49. ROMEO MAL, Martinelli V, Dalla Costa G, Colombo B, et al
    Assessing the role of innovative therapeutic paradigm on multiple sclerosis treatment response.
    Acta Neurol Scand. 2018 Jul 22. doi: 10.1111/ane.12999.
    PubMed     Abstract available


  50. HAFSTEINSDOTTIR B, Olafsson E, Jakobsson F
    Incidence and outcome of Guillain-Barre syndrome in Iceland: A population-based study.
    Acta Neurol Scand. 2018 Jul 17. doi: 10.1111/ane.13000.
    PubMed     Abstract available


  51. GAVRILOV YV, Shkilnyuk GG, Valko PO, Stolyarov ID, et al
    Validation of the Russian version of the Fatigue Impact Scale and Fatigue Severity Scale in multiple sclerosis patients.
    Acta Neurol Scand. 2018 Jul 9. doi: 10.1111/ane.12993.
    PubMed     Abstract available


  52. CANDELIERE MERLICCO A, Gabaldon Torres L, Villaverde Gonzalez R, Fernandez Romero I, et al
    Transorbital ultrasonography for measuring optic nerve atrophy in multiple sclerosis.
    Acta Neurol Scand. 2018 Jul 2. doi: 10.1111/ane.12976.
    PubMed     Abstract available


  53. JIN S, Long Z, Wang W, Jiang B, et al
    Hyponatremia in neuromyelitis optica spectrum disorders: Literature review.
    Acta Neurol Scand. 2018;138:4-11.
    PubMed     Abstract available


    June 2018
  54. DALE GH, Svendsen KB, Gjelstrup MC, Christensen T, et al
    Incidence of neuromyelitis optica spectrum disorder in the Central Denmark Region.
    Acta Neurol Scand. 2018;137:582-588.
    PubMed     Abstract available


    May 2018
  55. CEA G, Martinez D, Salinas R, Vidal C, et al
    Clinical and epidemiological features of myasthenia gravis in Chilean population.
    Acta Neurol Scand. 2018 May 29. doi: 10.1111/ane.12967.
    PubMed     Abstract available


  56. BERNTSSON SG, Kristoffersson A, Bostrom I, Feresiadou A, et al
    Rapidly increasing off-label use of rituximab in multiple sclerosis in Sweden - Outlier or predecessor?
    Acta Neurol Scand. 2018 May 24. doi: 10.1111/ane.12963.
    PubMed     Abstract available


  57. SEBASTIAO E, Motl RW
    Body mass index and cardiorespiratory fitness in persons with multiple sclerosis.
    Acta Neurol Scand. 2018 May 11. doi: 10.1111/ane.12959.
    PubMed     Abstract available


  58. ABDOLLAHPOUR I, Nedjat S, Mansournia MA, Eckert S, et al
    Infectious exposure, antibiotic use, and multiple sclerosis: A population-based incident case-control study.
    Acta Neurol Scand. 2018 May 9. doi: 10.1111/ane.12958.
    PubMed     Abstract available


  59. HONG Y, Li HF, Romi F, Skeie GO, et al
    HLA and MuSK-positive myasthenia gravis: A systemic review and meta-analysis.
    Acta Neurol Scand. 2018 May 7. doi: 10.1111/ane.12951.
    PubMed     Abstract available


  60. SHU Y, Chang Y, Wu H, Li J, et al
    Serum cystatin C and anti-N-methyl-D-aspartate receptor encephalitis.
    Acta Neurol Scand. 2018;137:515-522.
    PubMed     Abstract available


    April 2018
  61. AXELSSON M, Sjogren M, Andersen O, Blennow K, et al
    Neurofilament light protein levels in cerebrospinal fluid predict long-term disability of Guillain-Barre syndrome: A pilot study.
    Acta Neurol Scand. 2018 Apr 6. doi: 10.1111/ane.12927.
    PubMed     Abstract available


    March 2018
  62. HEYDARPOUR P, Manouchehrinia A, Beiki O, Mousavi SE, et al
    Smoking and worsening disability in multiple sclerosis: A meta-analysis.
    Acta Neurol Scand. 2018 Mar 15. doi: 10.1111/ane.12916.
    PubMed     Abstract available


  63. VISTBAKKA J, Sumelahti ML, Lehtimaki T, Elovaara I, et al
    Evaluation of serum miR-191-5p, miR-24-3p, miR-128-3p, and miR-376c-3 in multiple sclerosis patients.
    Acta Neurol Scand. 2018 Mar 12. doi: 10.1111/ane.12921.
    PubMed     Abstract available


  64. RAHMANZADEH R, Weber MS, Bruck W, Navardi S, et al
    B cells in multiple sclerosis therapy-A comprehensive review.
    Acta Neurol Scand. 2018 Mar 7. doi: 10.1111/ane.12915.
    PubMed     Abstract available


    February 2018
  65. MANI A, Chohedri E, Ravanfar P, Mowla A, et al
    Efficacy of group cognitive rehabilitation therapy in multiple sclerosis.
    Acta Neurol Scand. 2018 Feb 7. doi: 10.1111/ane.12904.
    PubMed     Abstract available


  66. GUGER M, Enzinger C, Leutmezer F, Kraus J, et al
    Real-life clinical use of natalizumab and fingolimod in Austria.
    Acta Neurol Scand. 2018;137:181-187.
    PubMed     Abstract available


  67. AI P, Zhang X, Xie Z, Liu G, et al
    The HMGB1 is increased in CSF of patients with an Anti-NMDAR encephalitis.
    Acta Neurol Scand. 2018;137:277-282.
    PubMed     Abstract available


  68. NICKEL S, von dem Knesebeck O, Kofahl C
    Self-assessments and determinants of HRQoL in a German MS population.
    Acta Neurol Scand. 2018;137:174-180.
    PubMed     Abstract available


  69. FALIP M, Rodriguez-Bel L, Castaner S, Miro J, et al
    Musicogenic reflex seizures in epilepsy with glutamic acid decarbocylase antibodies.
    Acta Neurol Scand. 2018;137:272-276.
    PubMed     Abstract available


    January 2018
  70. CHANDAN S, Shukla G, Gupta A, Srivastava A, et al
    Acute-onset Restless legs syndrome in acute neurological conditions-a prospective study on patients with the Guillain-Barre syndrome and acute stroke.
    Acta Neurol Scand. 2018 Jan 22. doi: 10.1111/ane.12890.
    PubMed     Abstract available


  71. MESCHERIAKOVA JY, Hintzen RQ
    No excess of autoimmune diseases in multiple sclerosis families from the Netherlands.
    Acta Neurol Scand. 2018 Jan 7. doi: 10.1111/ane.12896.
    PubMed     Abstract available


  72. RORSMAN I, Petersen C, Nilsson PC
    Cognitive functioning following one-year natalizumab treatment: A non-randomized clinical trial.
    Acta Neurol Scand. 2018;137:117-124.
    PubMed     Abstract available


    December 2017
  73. OLSSON A, Oturai AB, Sondergaard HB, Sellebjerg F, et al
    Bone microarchitecture and bone mineral density in multiple sclerosis.
    Acta Neurol Scand. 2017 Dec 21. doi: 10.1111/ane.12884.
    PubMed     Abstract available


  74. ZECCA C, Antozzi CG, Torri Clerici V, Ferrazzini M, et al
    Severe multiple sclerosis reactivation during prolonged lymphopenia after dimethyl fumarate discontinuation.
    Acta Neurol Scand. 2017 Dec 3. doi: 10.1111/ane.12882.
    PubMed     Abstract available


  75. HEESEN C, Haase R, Melzig S, Poettgen J, et al
    Perceptions on the value of bodily functions in multiple sclerosis.
    Acta Neurol Scand. 2017 Dec 3. doi: 10.1111/ane.12881.
    PubMed     Abstract available


    November 2017
  76. IBRAHIM J, Grapperon AM, Manfredonia F, van den Bergh PY, et al
    Serial electrophysiology in Guillain-Barre syndrome: A retrospective cohort and case-by-case multicentre analysis.
    Acta Neurol Scand. 2017 Nov 21. doi: 10.1111/ane.12872.
    PubMed     Abstract available


  77. ZETTERBERG H
    Fluid biomarkers for microglial activation and axonal injury in multiple sclerosis.
    Acta Neurol Scand. 2017;136 Suppl 201:15-17.
    PubMed     Abstract available


  78. LYCKE J
    Trials of antivirals in the treatment of multiple sclerosis.
    Acta Neurol Scand. 2017;136 Suppl 201:45-48.
    PubMed     Abstract available


  79. CELIUS EG
    Infections in patients with multiple sclerosis: Implications for disease-modifying therapy.
    Acta Neurol Scand. 2017;136 Suppl 201:34-36.
    PubMed     Abstract available


  80. WEKERLE H
    Nature, nurture, and microbes: The development of multiple sclerosis.
    Acta Neurol Scand. 2017;136 Suppl 201:22-25.
    PubMed     Abstract available


  81. FREDERIKSEN JL, Topsoe Mailand M
    Vaccines and multiple sclerosis.
    Acta Neurol Scand. 2017;136 Suppl 201:49-51.
    PubMed     Abstract available


  82. WENDEL-HAGA M, Celius EG
    Is the hygiene hypothesis relevant for the risk of multiple sclerosis?
    Acta Neurol Scand. 2017;136 Suppl 201:26-30.
    PubMed     Abstract available


    August 2017
  83. WALLIN MT, Culpepper WJ, Maloni H, Kurtzke JF, et al
    The Gulf War era multiple sclerosis cohort: 3. Early clinical features.
    Acta Neurol Scand. 2017 Aug 22. doi: 10.1111/ane.12810.
    PubMed     Abstract available


    July 2017
  84. ANDERSEN O, Hildeman A, Longfils M, Tedeholm H, et al
    Diffusion tensor imaging in multiple sclerosis at different final outcomes.
    Acta Neurol Scand. 2017 Jul 25. doi: 10.1111/ane.12797.
    PubMed     Abstract available


  85. CAMBRON M, Hadhoum N, Duhin E, Lacour A, et al
    JCV serology in time: 3 years of follow-up.
    Acta Neurol Scand. 2017;136:54-58.
    PubMed     Abstract available


    June 2017
  86. GUAN Z, Shang L, Zhang W, Guo Y, et al
    A rating scale for the severity of Guillain-Barre syndrome.
    Acta Neurol Scand. 2017 Jun 14. doi: 10.1111/ane.12786.
    PubMed     Abstract available


  87. OTTO M, Markvardsen L, Tankisi H, Jakobsen J, et al
    The electrophysiological response to immunoglobulin therapy in chronic inflammatory demyelinating polyneuropathy.
    Acta Neurol Scand. 2017;135:656-662.
    PubMed     Abstract available


    May 2017
  88. MENTIS AA, Dardiotis E, Grigoriadis N, Petinaki E, et al
    Viruses and endogenous retroviruses in multiple sclerosis: From correlation to causation.
    Acta Neurol Scand. 2017 May 23. doi: 10.1111/ane.12775.
    PubMed     Abstract available


    April 2017
  89. MARTINELLI V, Dalla Costa G, Messina MJ, Di Maggio G, et al
    Multiple biomarkers improve the prediction of multiple sclerosis in clinically isolated syndromes.
    Acta Neurol Scand. 2017 Apr 9. doi: 10.1111/ane.12761.
    PubMed     Abstract available


    March 2017
  90. ELKJAER ML, Molnar T, Illes Z
    Teriflunomide for multiple sclerosis in real-world setting.
    Acta Neurol Scand. 2017 Mar 20. doi: 10.1111/ane.12755.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: